ITRASPHERE SB-130 CAPSULES
ITRASPHERE SB-130 CAPSULES
Itraconazole 130 mg
- FDA, CDSCO and DCGI approved broad-spectrum triazole with antifungal activity.
- Advantage of improved gastrointestinal tolerability than the liquid formulation.
- Exhibits higher complete cure rate and more consistent delivery at target site due to high sebum concentrations in case of dermatophytosis.
- Rapid and greater antifungal efficacy and better skin penetration.
Indications
- Blastomycosis
- Histoplasmosis
- Aspergillosis
- Dermatophytosis